LWM
GILD icon

Lodestone Wealth Management’s Gilead Sciences GILD Stock Holding History

Lodestone Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$112K Sell
886
-56
-6% -$7.38K 0.04% 227
2026
Q1 		$131K Buy
942
+6
+0.6% +$840 0.05% 196
2025
Q4 		$115K Buy
+936
New +$114K 0.05% 204

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Lodestone Wealth Management's GILD Position: Q2 2026 in Review

Lodestone Wealth Management reduced its Gilead Sciences (GILD) stake by 5.9% in Q2 2026, selling an estimated $7.38K and leaving 886 shares worth $112K. The position accounts for 0.04% of the portfolio, ranked #227.

Lodestone Wealth Management first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $131K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Lodestone Wealth Management held 886 shares of Gilead Sciences worth $112K as of Q2 2026.
  • Lodestone Wealth Management sold 56 Gilead Sciences shares in Q2 2026, an estimated $7.38K.
  • Gilead Sciences made up 0.04% of Lodestone Wealth Management's portfolio in Q2 2026, its #227 holding.
  • Lodestone Wealth Management first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • Lodestone Wealth Management's Gilead Sciences position peaked at $131K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Lodestone Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.